glucose, (beta-d)-isomer has been researched along with Chronic Kidney Failure in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (20.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 10 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baczyk, K; Czarnecki, R; Siekierka, H; Wierusz-Wysocka, B; Wysocki, H; Wysocki, K | 1 |
| Galwas, B; Grzeszczak, W; Jendryczko, A; Zukowska-Szczechowska, E | 1 |
| Ringoir, S; Vanholder, R | 1 |
| Acerbi, MA; Cappelli, G; Lucchi, L; Lusvarghi, E; Spattini, A | 1 |
| Asscher, AW; Eckardt, H; Eckardt, KU; Harber, MJ | 1 |
| Cherney, DZI; Chertow, GM; Correa-Rotter, R; Heerspink, HJL; Jongs, N; Langkilde, AM; Mann, JFE; McMurray, JJV; Mosenzon, O; Rossing, P; Stefansson, BV; Toto, RD; Vart, P; Waijer, SW; Wheeler, DC | 1 |
| Grätzel von Grätz, P | 1 |
| Cooper, ME; Koitka-Weber, A; Perkovic, V; Pfarr, E; Schernthaner, G; von Eynatten, M; Wanner, C; Woerle, HJ | 1 |
| Altay, H; Cahn, A; Çavuşoğlu, Y; Celik, A; Demir, S; Kılıçaslan, B; Nalbantgil, S; Raz, I; Temizhan, A; Yıldırımtürk, Ö; Yılmaz, MB | 1 |
| Li, J; Tan, R; Wang, L; Zhao, S; Zhong, X | 1 |
| Chertow, GM; Correa-Rotter, R; Greene, T; Heerspink, HJL; Hou, FF; Langkilde, AM; Lindberg, M; Mann, JFE; McMurray, JJV; Rossing, P; Sjöström, CD; Stefánsson, BV; Toto, RD; Wheeler, DC | 1 |
| Doumas, M; Imprialos, K; Papadopoulos, C; Patoulias, D; Stavropoulos, K | 1 |
| Chertow, GM; Correa-Rotter, R; Greene, T; Heerspink, HJL; Hou, FF; Jongs, N; Langkilde, AM; McMurray, JJV; Rossing, P; Sjöström, CD; Stefánsson, BV; Toto, RD; Wheeler, DC | 1 |
| LeMaistre, FI; Molony, DA | 1 |
| Brodovicz, KG; Chung, WJ; Deruaz-Luyet, A; H-H Sheu, W; Ha, KH; Kim, DJ; Klement, R; Kyaw, MH; Lee, S; Lei, WY; Nangaku, M; Node, K; Seino, Y; Tan, EC; Yabe, D; Yasui, A | 1 |
| Alperin, P; Cohen, M; Dziuba, J; Goswami, D; Grossman, HL; Hardy, E; Iloeje, U; Perlstein, I; Racketa, J | 1 |
| Busetto, L; Fioretto, P; Rossato, M; Vettor, R; Zambon, A | 1 |
| Avogaro, A; Fioretto, P | 1 |
| Hao, LH; Li, W; Qi, Y; Tong, YF; Wu, S; Wu, XF; Yang, QY | 1 |
| Barenghi, L; Bonini, PA; Ceriotti, F; Murone, M; Pontillo, M | 1 |
3 review(s) available for glucose, (beta-d)-isomer and Chronic Kidney Failure
| Article | Year |
|---|---|
Phagocytic function in the uremic patient.
Topics: Humans; In Vitro Techniques; Kidney Failure, Chronic; Kidney Transplantation; Latex; Peritoneal Dialysis, Continuous Ambulatory; Phagocytosis; Renal Dialysis; Uremia; Zymosan | 1992 |
Meta-analysis of Dedicated Renal Outcome Trials Assessing the Cardio-renal Efficacy of Sodium-Glucose Co-transporter-2 Inhibitors in Patients With Chronic Kidney Disease and Albuminuria.
Topics: Albuminuria; Benzhydryl Compounds; Canagliflozin; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucosides; Heart Failure; Hospitalization; Humans; Kidney Failure, Chronic; Renal Insufficiency, Chronic; Renal Replacement Therapy; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Dapagliflozin: potential beneficial effects in the prevention and treatment of renal and cardiovascular complications in patients with type 2 diabetes.
Topics: Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucosides; Humans; Hyperglycemia; Hypoglycemic Agents; Kidney Failure, Chronic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2017 |
4 trial(s) available for glucose, (beta-d)-isomer and Chronic Kidney Failure
| Article | Year |
|---|---|
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial.
Topics: Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glomerular Filtration Rate; Glucosides; Heart Failure; Humans; Kidney; Kidney Failure, Chronic; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
Choice of endpoint in kidney outcome trials: considerations from the EMPA-REG OUTCOME® trial.
Topics: Benzhydryl Compounds; Creatinine; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glomerular Filtration Rate; Glucosides; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prognosis; Sodium-Glucose Transporter 2 Inhibitors; Survival Rate | 2020 |
Dapagliflozin in Patients with Chronic Kidney Disease.
Topics: Aged; Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glucosides; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Regression Analysis; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial.
Topics: Adult; Aged; Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Glucosides; Heart Failure; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Renal Insufficiency, Chronic; Treatment Outcome | 2021 |
13 other study(ies) available for glucose, (beta-d)-isomer and Chronic Kidney Failure
| Article | Year |
|---|---|
Influence of hemodialysis on plasma chemotactic activity and the chemotactic responsiveness of polymorphonuclear neutrophils.
Topics: Adult; Blood Physiological Phenomena; Cellophane; Chemotactic Factors; Chemotaxis, Leukocyte; Humans; Kidney Failure, Chronic; Long-Term Care; Neutrophils; Renal Dialysis; Zymosan | 1983 |
[Release of superoxide anions by lymphocytes in patients with chronic renal failure].
Topics: Adult; Analysis of Variance; Female; Humans; Kidney Failure, Chronic; Lymphocytes; Male; Middle Aged; Renal Dialysis; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1994 |
Oxidative metabolism of polymorphonuclear leukocytes and serum opsonic activity in chronic renal failure.
Topics: Humans; Kidney Failure, Chronic; Luminescent Measurements; Neutrophils; Opsonin Proteins; Oxidation-Reduction; Phagocytosis; Renal Dialysis; Rest; Zymosan | 1989 |
Analysis of polymorphonuclear leukocyte respiratory burst activity in uremic patients using whole-blood chemiluminescence.
Topics: Acridines; Adult; Aged; Female; Humans; Kidney Failure, Chronic; Leukocyte Count; Luminescent Measurements; Luminol; Male; Middle Aged; Neutrophils; Time Factors; Uremia; Zymosan | 1986 |
Topics: Benzhydryl Compounds; Glucosides; Humans; Kidney Failure, Chronic; Renal Insufficiency, Chronic | 2022 |
[Sodium glucose co-transporter 2 inhibitors in heart failure therapy].
Topics: Aged; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Diastole; Diuresis; Female; Glucosides; Glycosuria; Heart Failure; Heart Ventricles; Hospitalization; Humans; Kidney Failure, Chronic; Male; Middle Aged; Mortality; Myocardium; Natriuresis; Physical Endurance; Quality of Life; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2 Inhibitors; Walk Test | 2020 |
Nodakenin alleviated obstructive nephropathy through blunting Snail1 induced fibrosis.
Topics: Angelica; Animals; Anti-Inflammatory Agents; Coumarins; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Glucosides; Humans; Kidney; Kidney Failure, Chronic; Macrophages; Mice; NF-kappa B; Phosphorylation; Plant Roots; Signal Transduction; Smad3 Protein; Snail Family Transcription Factors; Transforming Growth Factor beta1; Ureteral Obstruction | 2020 |
In CKD, dapagliflozin reduced a composite of eGFR decline, end-stage kidney disease, or CV or renal mortality.
Topics: Benzhydryl Compounds; ErbB Receptors; Glomerular Filtration Rate; Glucosides; Humans; Kidney Failure, Chronic; Renal Insufficiency, Chronic | 2021 |
Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asia, Eastern; Benzhydryl Compounds; Data Analysis; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Follow-Up Studies; Glucosides; Heart Failure; Humans; Kidney Failure, Chronic; Male; Middle Aged; Risk; Treatment Outcome; Young Adult | 2021 |
Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes.
Topics: Amputation, Surgical; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Weight; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Disease Progression; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incidence; Kidney Failure, Chronic; Metformin; Microcirculation; Middle Aged; Myocardial Infarction; Nutrition Surveys; Sodium-Glucose Transporter 2 Inhibitors; Stroke; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Uric Acid | 2014 |
SGLT2 Inhibitors and the Diabetic Kidney.
Topics: Albuminuria; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glomerular Filtration Rate; Glucosides; Humans; Hypoglycemic Agents; Kidney; Kidney Failure, Chronic; Kidney Glomerulus; Renin-Angiotensin System; Risk Factors; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2016 |
Total synthesis of adicardin.
Topics: Glucosides; Hydrangea; Kidney Failure, Chronic; Molecular Structure; Stereoisomerism; Umbelliferones | 2009 |
Optimization of the urinary acid alpha-glucosidase determination.
Topics: alpha-Glucosidases; Chromatography, Gel; Drug Stability; Glucosidases; Glucosides; Humans; Indicators and Reagents; Kidney Failure, Chronic; Kidney Transplantation; Kinetics; Reference Values; Spectrophotometry | 1985 |